Treatment of uncomplicated urinary tract infections / U.S. registration for Bayer's Cipro(R) XR antibiotic / Once-a-day dosing simplifies administration
Leverkusen (ots) - The U.S. Food and Drug Administration (FDA) has approved Bayer's antibiotic product Cipro(R) XR (Ciprofloxacin Extended-Release Tablets). This new formulation, given once a day over three days, is designed to treat uncomplicated urinary tract infections (UTIs). Cipro(R) XR will be marketed in a ...
mehr